Señales en vivo de NMRD | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 may 2024 @ 13:50):

Stats
Volumen de hoy	1 062.00
Volumen promedio	44 121.00
Capitalización de mercado	962 350
EPS	$-0.0700 ( 2024-02-23 )
Próxima fecha de ganancias	( $-0.110 ) 2024-07-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0900
ATR14	$0.00400 (12.01%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-05	Ghadar-ghadr Arash	Buy	100 000	Common Stock
2022-01-05	Ghadar-ghadr Arash	Buy	0
2022-01-28	Natha Salim	Buy	8 000	Stock Option (right to buy)
2022-01-28	Moore Thomas Peter	Buy	8 000	Stock Option (right to buy)
2022-01-31	Mclarney Justin James	Buy	22 293	Common Stock

INSIDER POWER
100.00
Last 26 transactions
Buy: 137 623 617 \| Sell: 137 373 875

Nemaura Medical Inc Correlación

10 Correlaciones Más Positivas
BJDX	0.936
BXRX	0.923
ALVR	0.884
AGIL	0.879
MIST	0.87
CTSO	0.87
BNDX	0.869
ADN	0.864
NEO	0.853
EJH	0.848

10 Correlaciones Más Negativas
ARCE	-0.949
DSKE	-0.924
TIG	-0.898
XOMAP	-0.893
MRM	-0.892
IMRA	-0.883
NESR	-0.867
SGII	-0.866
NSTS	-0.849
ORTX	-0.847

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nemaura Medical Inc Finanzas

Annual	2023
Ingresos:	$77 044.00
Beneficio Bruto:	$-1.48M (-1 916.30 %)
EPS:	$-1.010

FY	2023
Ingresos:	$77 044.00
Beneficio Bruto:	$-1.48M (-1 916.30 %)
EPS:	$-1.010

FY	2022
Ingresos:	$503 906
Beneficio Bruto:	$159 606 (31.67 %)
EPS:	$-0.590

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.280

Financial Reports:

No articles found.

Nemaura Medical Inc

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.